Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Eric Fader who wrote (1405)	11/5/1999 10:34:00 AM
From: Eric Fader	Read Replies (2) \| Respond to of 5582

A voice of reason on the idiot thread: It matters little because GUMM got what it wanted, national coverage of their product. I doubt that the withdrawal of the article will get on the front page of even one newspaper or make it to the evening news. Message 11819431

To: Eric Fader who wrote (1405)	11/5/1999 10:41:00 AM
From: Sir Auric Goldfinger	Respond to of 5582

Pffft: "GumTech Article on Nasal Spray Withdrawn From Medical Journal Woodland Hills, California, Nov. 5 (Bloomberg) -- GumTech International Inc. said an article on a nasal spray used to flight colds, which it markets in a joint venture, is being withdrawn from publication following publicity about the study. The article on nonprescription nasal spray Zicam was to be published in the February issue of the American Journal of Infection Control. The article was withdrawn because of the early release of data and other issues that failed to comply with the Journal's policies and copyright regulations, GumTech said in a statement. Shares of GumTech rose 18 percent Monday after the company said the study was due to be published. GumTech rose 1 1/8 to 18 yesterday. Zinc-based Zicam appears to cut the length of cold symptoms by about two days, Woodland Hills, California-based GumTech said. The spray sells for about $10 a bottle. It is marketed by Gel Tech LLC, a joint venture between Phoenix-based GumTech, a maker of chewing gum designed to provide health benefits, and closely held BioDelivery Technologies Inc. --Samantha Zee in the San Francisco newsroom (415) 912-2980/dfr"